Home » Topics » Regulatory

Regulatory
RSS

Vimpat approved in the E.U. for partial-onset seizures

Sep. 3, 2008

SF-1019 approved in Malaysia

Aug. 13, 2008

FDA approves Cleviprex for hypertension when oral therapy is not feasible

Aug. 5, 2008

European Commission approves Schering-Plough's Bridion

July 30, 2008

Health Canada grants approval to Santhera's Catena in Friedreich's ataxia

July 25, 2008

Jerini receives European approval for Firazyr for hereditary angioedema

July 16, 2008

Tredaptive approved in E.U. for dyslipidemia and primary hypercholesterolemia

July 14, 2008

Health Canada grants marketing authorization to Basilea's Zeftera for cSSSI

July 2, 2008

German approval for Oralair Grasses

June 30, 2008

FDA approves Sirion's NDA for Durezol in postoperative ocular inflammation and pain

June 27, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...